C-reactive protein as a predictor of hypertension in the Hong Kong Cardiovascular Risk Factor Prevalence Study (CRISPS) cohort

Area of Science:

• Cardiovascular Medicine
• Genetics
• Inflammation Research

Background:

• Inflammation is implicated in hypertension development.
• The causal role of C-reactive protein (CRP) in hypertension is not fully understood.
• Investigating genetic factors, like CRP gene single-nucleotide polymorphisms (SNPs), offers insight into hypertension etiology.

Purpose of the Study:

• To examine the association between circulating CRP levels and hypertension.
• To determine if CRP gene SNPs influence plasma CRP levels and hypertension risk.

Main Methods:

• Plasma CRP levels and genotypes of nine CRP gene SNPs were analyzed in 1925 subjects.
• Longitudinal follow-up assessed hypertension development in 1115 initially normotensive individuals.
• Statistical analyses correlated CRP levels and SNPs with incident hypertension.

Main Results:

• Elevated plasma CRP was independently associated with an increased risk of developing hypertension.
• Six CRP gene SNPs significantly correlated with plasma CRP levels.
• No significant association was found between CRP gene SNPs and blood pressure or hypertension incidence.

Conclusions:

• Plasma CRP levels are a significant predictor of future hypertension.
• While CRP gene variants affect CRP levels, they do not appear to directly influence hypertension risk in this cohort.
• Plasma CRP, rather than CRP gene SNPs, is more strongly related to hypertension risk.